SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Blickensdoerfer Hans-Martin

(Last)

(First)

(Middle)

1911 WALKER AVENUE

(Street)

MONROVIA

91016

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2015

3. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Int'l Commercial Op

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	81,700⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock Options (right to buy)	⁽²⁾	02/09/2016	Common Stock	25,000	$6.92	D
Common Stock Options (right to buy)	⁽³⁾	04/01/2017	Common Stock	25,000	$5.39	D
Common Stock Options (right to buy)	⁽⁴⁾	12/14/2020	Common Stock	25,000	$5.68	D
Common Stock Options (right to buy)	⁽⁵⁾	03/14/2021	Common Stock	20,000	$5.49	D
Common Stock Options (right to buy)	⁽⁶⁾	03/01/2022	Common Stock	20,000	$11	D
Common Stock Options (right to buy)	⁽⁷⁾	03/03/2023	Common Stock	20,000	$5.34	D
Common Stock Options (right to buy)	⁽⁸⁾	03/06/2024	Common Stock	15,000	$15.54	D
Common Stock Options (right to buy)	⁽⁹⁾	04/06/2025	Common Stock	30,000	$7.35	D

Explanation of Responses:

1. Includes 7,500 Performance Accelerated Restricted Shares of Common Stock (PARS), subject to forfeiture rights, which lapse on March 4, 2016, but subject to accelerated lapse of the forfeiture rights as to 1/3 of the shares each year pursuant to achievement of crtain performance criteria. Also includes 7,000 Restricted Shares of Common Stock (RSU), subject to forfeiture rights, which lapse as to half of the shares (3500 shares) on March 7, 2016 and half of the shares (3500 shares) on March 7, 2017. Also includes 15,000 Restricted Shares of Common Stock (RSU), subject to forfeiture rights, which lapse as to half of the shares (7500 shares) on April 7, 2017 and half of the shares (7500 shares) on April 7, 2018.

2. The option becomes exercisable in three equal installments beginning February 10, 2007.

3. The option becomes exercisable in three equal installments beginning April 2, 2008.

4. The option becomes exercisable in three equal installments beginning December 15, 2011.

5. The option becomes exercisable in three equal installments beginning March 15, 2012.

6. The option becomes exercisable in three equal installments beginning March 2, 2013.

7. The option becomes exercisable in three equal installments beginning March 4, 2014.

8. The option becomes exercisable in three equal installments beginning March 7, 2015.

9. The option becomes exercisable in three equal installments beginning April 7, 2016.

	/s/ Samuel Gesten as attorney-in-fact for Hans-Martin Blickensdoerfer	05/01/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.